|
![]() |
|||
|
||||
OverviewFull Product DetailsAuthor: Elizabeth A. Eisenhauer (Head, Department of Oncology; Medical Director, Oncology Program, Queen's University, Kingston General Hospital, Cancer Centre of Southeastern Ontario) , Christopher Twelves (Professor of Clinical Pharmacology and Oncology; Head, Section of Clinical Cancer Research Groups, Leeds Institute of Molecular Medicine, St. James's Institute of Oncology) , Marc Buyse (Founder and Chairman; Associate Professor of Biostatistics, International Drug Development Institute; Universiteit Hasselt)Publisher: Oxford University Press Inc Imprint: Oxford University Press Inc Edition: 2nd Revised edition Dimensions: Width: 15.60cm , Height: 1.70cm , Length: 23.40cm Weight: 0.522kg ISBN: 9780199359011ISBN 10: 0199359016 Pages: 368 Publication Date: 01 June 2014 Audience: Professional and scholarly , Professional & Vocational Format: Paperback Publisher's Status: Active Availability: To order ![]() Stock availability from the supplier is unknown. We will order it for you and ship this item to you once it is received by us. Table of Contents1. Introduction ; 2. Preclinical Data and Requirements ; 3. Phase 0 Clinical Trials ; 4. Basics of Phase I Design: First-in-man Studies ; 5. Ethical Issues in First-in-human Phase I Cancer Trials ; 6. Phase I Trials in Special Populations and Circumstances ; 7. Phase I Trials of Immunotherapeutics ; 8. Statistical Designs for First-in-human Phase I Trials ; 9. Writing the Protocol ; 10. Practical Aspects of Pharmacokinetics and Pharmacodynamics ; 11. Process, Pitfalls, and Logistics of Phase I Trials ; 12. Reporting and Interpreting Results ; Appendix: Useful Web ResourcesReviewsPhase I Cancer Clinical Trials: A Practical Guide, 2nd Edition is an indispensable guide for the specialized world of Phase I cancer studies. -- Journal of Clinical Research Best Practices This is a well-written, well-structured book that comprehensively covers the unique aspects of phase I clinical trials in cancer patients. This may be the only book of its kind and will be appropriate for a wide audience. Karen L. Reckamp, MD, MS; Doodys Reviews Author InformationEAE: Head, Department of Oncology, Queen's University, Medical Director, Oncology Program, Kingston General Hospital, Cancer Centre of Southeastern Ontario, Kingston, Canada; CT: Professor of Clinical Pharmacology and Oncology, Head, Section of Clinical Cancer Research Groups, Leeds Institute of Cancer Studies and Pathology, St. James's Institute of Oncology Leeds, UK; MB: Founder and Chairman, International Drug Development Institute, Louvain-la-Neuve, Belgium, Associate Professor of Biostatistics, Universiteit Hasselt Diepenbeek, Belgium Tab Content 6Author Website:Countries AvailableAll regions |